Year archive

AFT PHARMACEUTICALS LIMITED — 2017 filings

All 53 regulatory filings released by AFT PHARMACEUTICALS LIMITED (AFP) in 2017, sourced directly from the official regulator.

53 Filings

2017 Period

2017 filings (53)

Filing	Released	Lang
AFP painkiller Maxigesic now licensed in Mexico 2 pages 50.2KB Capital/Financing Update	2017-12-26	English
Updated FY18H1 Presentation 13 pages 2.4MB Investor Presentation	2017-11-23	English
Half Yearly Report and Accounts 6 pages 185.7KB Interim / Quarterly Report	2017-11-22	English
Half Yearly Report and Accounts 2 pages 119.5KB Interim / Quarterly Report	2017-11-22	English
Half Yearly Report and Accounts 26 pages 863.3KB Interim / Quarterly Report	2017-11-22	English
Half Yearly Report and Accounts 13 pages 2.4MB Investor Presentation	2017-11-22	English
to announce half year results on Thursday November 23 2017 1 Regulatory Filings	2017-10-15	English
Positive result from large US clinical trial for Maxigesic I 3 pages 55.9KB Regulatory Filings	2017-10-11	English
170929 Market Update 3 pages 41.5KB Capital/Financing Update	2017-09-28	English
170928 AFT Pharmaceuticals Presentation ASX 12 pages 2.4MB Investor Presentation	2017-09-27	English
AFT Pharmaceuticals celebrates 20 years of success 3 pages 55.1KB Regulatory Filings	2017-08-31	English
NZSA presentation 15 pages 2.6MB Investor Presentation	2017-08-20	English
AFP supports Commerce Commission recommendations 2 pages 48.1KB Regulatory Filings	2017-08-16	English
Resignation of Head of International Business and Business D 1 Board/Management Information	2017-08-07	English
2017 annual meeting - chairman speech 4 pages 67.2KB AGM Information	2017-08-03	English
2017 Annual Meeting presentation 17 pages 2.5MB Investor Presentation	2017-08-03	English
2017 Annual Meeting Results 2 pages 39.9KB Declaration of Voting Results & Voting Rights Announcements	2017-08-03	English
Maxigesic now licensed in 124 countries 4 pages 80.1KB Capital/Financing Update	2017-07-19	English
AFP Notice of Annual Meeting of Shareholders 2017 4 pages 348.7KB AGM Information	2017-07-10	English
AFT Sample proxy 2017 meeting 2 pages 94.6KB AGM Information	2017-07-10	English
disclosure notice 1 page 94.2KB Director's Dealing	2017-07-06	English
disclosure notice 2 pages 108.0KB Director's Dealing	2017-06-18	English
disclosure notice 2 pages 80.8KB Director's Dealing	2017-06-18	English
disclosure notice 2 pages 104.7KB Director's Dealing	2017-06-18	English
disclosure notice 2 pages 99.9KB Director's Dealing	2017-06-18	English
disclosure notice 2 pages 80.1KB Director's Dealing	2017-06-18	English
Appendix 3B - Security Purchase Plan 17 pages 180.5KB Capital/Financing Update	2017-06-14	English
Successful share purchase plan for AFT Pharmaceuticals 1 Share Issue/Capital Change	2017-06-13	English
Annual Report to shareholders 37 pages 1.9MB Annual Report	2017-06-12	English
form 209 1 page 284.1KB Report Publication Announcement	2017-06-12	English
Annual Meeting and Closing Date for Director Nominations 1 AGM Information	2017-05-31	English
Preliminary Final Report 6 pages 219.4KB Annual Report	2017-05-23	English
Full Year Announcement App I 3 pages 119.5KB Earnings Release	2017-05-23	English
2017 Financial Statements 31 pages 392.2KB Annual Report	2017-05-23	English
AFT Pharmaceuticals Presentation FY2017 Full Year Update 16 pages 1.7MB Investor Presentation	2017-05-23	English
Security Purchase Plan 1 page 44.9KB Capital/Financing Update	2017-05-23	English
Security Purchase Plan 2 pages 104.0KB Capital/Financing Update	2017-05-23	English
Security Purchase Plan 22 pages 1.9MB Capital/Financing Update	2017-05-23	English
Security Purchase Plan 4 pages 82.3KB Capital/Financing Update	2017-05-23	English
Security Purchase Plan 4 pages 73.4KB Capital/Financing Update	2017-05-23	English
Maxigesic now licensed in France 2 pages 52.8KB Capital/Financing Update	2017-05-21	English
Further European approvals for Maxigesic 2 pages 55.3KB Regulatory Filings	2017-05-18	English
Maxigesic on track to access the large United States market 2 pages 100.7KB Capital/Financing Update	2017-05-11	English
AFT Pharmaceuticals to announce full year results on May 24 1 Report Publication Announcement	2017-05-08	English
AFT Pharmaceuticals Presentation - Woodward partners 10 pages 974.0KB Investor Presentation	2017-04-11	English
170329 1 Notice Pursuant to Listing rule 7.12.1 2 pages 71.7KB Capital/Financing Update	2017-03-29	English
AFP In-Licenses NovaTears in Australia and New Zealand 3 pages 142.3KB Capital/Financing Update	2017-03-20	English
RPS SPP Announcement 4 pages 115.2KB Capital/Financing Update	2017-03-16	English
AFT Pharmaceuticals Presentation - Business Update 11 pages 946.4KB Capital/Financing Update	2017-03-16	English
DirectorsandOfficersOngoingDisclosureNotice-JB 1 pa Director's Dealing	2017-02-28	English
Market Update 2 pages 73.8KB Capital/Financing Update	2017-02-16	English
2017 New Year Letter to Investors 6 pages 98.5KB Management Reports	2017-01-15	English
AFT Maxigesic License for Nordics with Weifa 2 pages 75.7KB Regulatory Filings	2017-01-11	English

Filings by year

2026 14 filings
2025 29 filings
2024 37 filings
2023 36 filings
2022 43 filings
2021 47 filings
2020 75 filings
2019 35 filings
2018 29 filings
2017 53 filings
2016 38 filings
2015 25 filings